Vasopressin (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Vasopressin drug offered from Fresenius Kabi USA, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: VASOPRESSIN
SUBSTANCE NAME: VASOPRESSIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2001-07-17
END MARKETING DATE: 0000-00-00


Vasopressin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVasopressin from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 20([USP’U]/mL)
START MARKETING DATE: 2001-07-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-302_b2ef839e-8e4a-482a-8998-b8ac75b138ef
PRODUCT NDC: 63323-302
APPLICATION NUMBER:

Other VASOPRESSIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthVasopressin
Feneral Injectables & Vaccines, IncVASOPRESSIN
Fresenius Kabi USA, LLCVasopressin